Akuru Pharma is a spin out company from Lund University working to develop novel transporter protein-based diagnostics and treatment modalities for kidney cancer.
| Website | http://www.akurupharma.com |
| Revenue | $4 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2016 |
| Address | Medicon Vlg, Lund, Skane 22350, SE |
| Phone | +46 70 214 56 73 |
| Technologies |
JavaScript
,
HTML
,
Nginx
+2 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare |
| Keywords | Innovative Cancer Treatments, Kidney Cancer Treatment, Oncology Drug Development, Pharmaceutical Research, Cancer Diagnostics, Cancer Research, Drug Delivery Systems, Biopharmaceutical Development, Advanced Drug Delivery, Targeted Cancer Therapy, Precision Oncology, Cancer Biomarkers, Therapeutic Proteins, Clinical Stage Drug |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, Bayer, GSK, AstraZeneca +47 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Akuru Pharma AB employee's phone or email?
Akuru Pharma AB Questions
The Akuru Pharma AB annual revenue was $4 million in 2026.
Akuru Pharma AB is based in Lund, Skane.
The NAICS codes for Akuru Pharma AB are [325, 32, 3254, 32541].
The SIC codes for Akuru Pharma AB are [28, 283].
Related Companies
G2Crowd Trusted
300K+
Plugin Users
